Joint Venture8 Sept 2025, 07:22 pm
Morepen Laboratories Subsidiary Executes Joint Venture Agreement with Bimedical FZE
AI Summary
Morepen Laboratories Ltd. announced that its subsidiary, Morepen Medipath Limited, has entered into a joint venture agreement with Bimedical FZE. The new joint venture company, yet to be named and incorporated, will carry on the business of manufacturing, trading, and selling medical devices related products. Morepen Laboratories and Bimedical FZE will contribute equally in the share capital of the proposed joint venture company. The proposed joint venture company will be related to Morepen Laboratories, with the company holding 30% shares indirectly through Morepen Medipath Limited.
Key Highlights
- Morepen Medipath Limited, a subsidiary of Morepen Laboratories, has executed a joint venture agreement with Bimedical FZE.
- A new joint venture company will be incorporated for manufacturing, trading, and selling medical devices related products.
- Morepen Laboratories and Bimedical FZE will contribute equally in the share capital of the proposed joint venture company.
- Morepen Laboratories will hold 30% shares in the proposed joint venture company indirectly through Morepen Medipath Limited.
- The proposed joint venture company will be related to Morepen Laboratories.